Former CEO of Novartis-Sandoz (South Africa) to Lead AAT Research’s Global Expansion
AAT Research, a research firm that designs and develops quality medical solutions in the neuroscience space, today announced that it has appointed pharmaceutical and medical industry veteran Wolfgang Storf as its new chief executive officer.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20160406005565/en/
Mr Storf brings more than 20 years of experience in the industry with a successful record of entering new markets, providing strategic direction and boosting growth.
Prior to joining AAT, he was chief strategy officer with the MS Pharma Group. He was also CEO of Novartis-Sandoz in South Africa and held other senior management positions with Novartis-Sandoz, Apotex and Johnson & Johnson in different regions of the world. Mr Storf is a seasoned senior executive with proven global strategic and execution leadership experience – covering both commercial and technical operations as well R&D responsibility inside multinational and private businesses in the pharmaceutical and medical industry. He also has experience in post-merger integration programs in both branded / un-branded markets.
“I am delighted to take over as CEO at this important stage of AAT’s growth, and I’m looking forward to working with the executive team and the board to help the company realise its full potential, enter new markets and establish our products as leading therapies and services for patients and medical professionals respectively,” Mr Storf said.
AAT Research’s Founder and Chief Scientific Officer, Dr Adrian Attard Trevsisan, said: “We have come a long way from a small one-room setup. As the company continues to grow and increase its international footprint, we felt the need to bring in a senior executive who has extensive international experience in the pharmaceutical and medical industries.”
“The board of directors and I are extremely pleased that Wolfgang has joined the company and he will be a determining factor in the internationalisation of AAT in the coming months. I will be taking on the role of Chief Scientific Officer and Director of Product, focusing on research, innovation and product development,” Dr Attard Trevisan added.
About AAT Research
The AAT Research group of companies researches, designs, develops and manufactures quality medical solutions. With regulatory and quality systems in place and various international accreditations to its name, the group aims to lead innovation in the neurosciences field. AAT’s purpose is to improve people’s lives though innovation in the field of neuroscience and medical technology and our mission is to develop quality medical devices and cloud-based services to help improve the lives of those with neurologically-based conditions such as autism, epilepsy, depression and anxiety. For more information visit: http://www.aatrl.com .
Tel: +356 21330588
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skriv dig op her og modtag pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Business Wire
LOXAM20.7.2018 16:53 | pressemeddelelse
Loxam Announces a Conditional Agreement to Acquire UK Platforms
SCHLUMBERGER-LIMITED20.7.2018 13:02 | pressemeddelelse
Schlumberger Announces Second-Quarter 2018 Results
FL-H.I.G.-CAPITAL19.7.2018 21:52 | pressemeddelelse
H.I.G. Capital Announces the Sale of KidsFoundation
SIG-COMBIBLOC-GROUP19.7.2018 18:03 | pressemeddelelse
SIG Combibloc Group Holdings S.à r.l.: 2018 Second Quarter Results
FL-NEORIS19.7.2018 17:34 | pressemeddelelse
NEORIS Announces Creation of Innovation Labs Worldwide to Create a Smarter Future
CQN-FLEXTRADE19.7.2018 17:31 | pressemeddelelse
CORRECTING and REPLACING Albar Capital Deploys FlexNOW
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum